DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 201 filers reported holding DIPLOMAT PHARMACY INC in Q4 2017. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $278,000 | – | 13,850 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cortina Asset Management, LLC | 1,417,396 | $28,447,000 | 1.25% |
| Investors Research Corp | 96,550 | $1,938,000 | 1.20% |
| Phocas Financial Corp. | 663,187 | $13,310,000 | 1.12% |
| BROADVIEW ADVISORS LLC | 338,000 | $6,784,000 | 0.96% |
| Matarin Capital Management, LLC | 581,129 | $11,663,259,000 | 0.91% |
| Sivik Global Healthcare LLC | 100,000 | $2,007,000 | 0.74% |
| Iguana Healthcare Management, LLC | 50,000 | $1,004,000 | 0.65% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,824,190 | $76,751,000 | 0.56% |
| Capital Impact Advisors, LLC | 63,403 | $1,272,000 | 0.55% |
| Tekla Capital Management LLC | 640,492 | $12,855,000 | 0.50% |